BTF is a critical lifeline for those who suffer from brain tumors.
Founded in 1998 by Dr. Patrick J. Kelly, the Brain Tumor Foundation (BTF) guides and supports patients and families during the turbulent times when their lives are touched by a brain tumor.
The Road to Early Detection Campaign, an initiative of the Brain Tumor Foundation, was launched to promote the early detection of brain tumors and brain scan screenings. The initial pilot program reached out to communities – particularly those under-served in the five boroughs of New York City.
Based on New York’s success, the Brain Tumor Foundation launched the National Sponsor-A-City Tour component beginning with Boston, continuing on to Philadelphia, New York, and Las Vegas. Additional cities are scheduled to be visited in the coming months.
In collaboration with a multi-disciplinary research team at Columbia University and the Mailman School for Public Health — comprised of experts in oncology, cancer epidemiology, neuroradiology, neurosurgery and neurology — BTF is gathering key information to help us better understand the relationship between patient factors and brain tumors.
Although MRI screening for brain tumors is not considered part of standard preventive care, we hope that our research examining the brain scans of thousands of individuals around the country will shed new light on brain tumors allowing for more effective treatment options and the prevention of this dreaded disease.
The Brain Tumor Foundation offers patients information on treatment options and referrals to appropriate clinical trials or brain tumor centers throughout the country.
BTF also produces informational events and utilizes social media outlets to dispense important medical updates, brain tumor news and alerts to patients and their families.
Tribute Dinner 2019
Over 700,000 people in the US will be diagnosed with a primary or metastatic brain tumor. That’s a huge patient population. It’s the equivalent of breast cancer, and more than Parkinson’s and Alzheimer’s. All of these diseases are receiving an incredible amount of public attention. It is our goal at the Brain Tumor Foundation to get the word out about the prevalence of this devastating disease.
Dr. Schulder is the Director of the Brain Tumor Center of the Northwell Neuroscience Institute, Director of the Neurosurgery Residency Program at the Zucker School of Medicine; and Co-Director of the Center for Stereotactic Radiosurgery at Northwell’s Cancer Institute. Dr. Schulder is the immediate past president of the World Society for Stereotactic and Functional Neurosurgery, as well as a past president of the American Society for Stereotactic and Functional Neurosurgery. He is also the founding Vice-President of the Intraoperative Imaging Society; a Director of the American Association of Neurological Surgeons, of which
he also is the Historian; and an elected member of the American Academy of Neurological Surgery and the Society of Neurological Surgeons. His research and publications have focused primarily on new techniques for image-guided surgery, including intraoperative MRI. He was the editor of AANS Neurosurgeon from 2010 to 2017.
His current research focuses on minimally invasive surgical techniques for patients with brain tumors, including stereotactic radiosurgery and laser interstitial thermal therapy. He also is working on developing new technology for intraoperative MRI. Other current duties include serving on several editorial boards including the Journal of Neurosurgery, Neurosurgery, and Stereotactic and Functional Neurosurgery. He is
the Secretary/Treasurer of the New York Society for Neurosurgery.
President Emeritus Dr. Philip E. Stieg
Dr. Stieg is Chairman of Weill Cornell Medical College Department of Neurological Surgery, Neurosurgeon-in-Chief at New York Presbyterian/Weill Cornell Medical Center and Chairman and Founder of the Weill Cornell Brain and Spine Center, which is the leading neuroscience patient care center in New York City. He is a widely published author and internationally known lecturer, and for more than 20 years has been consistently named one of the nation’s Top Doctors by Castle Connolly.
New York City’s interdisciplinary neuroscience patient care center for the comprehensive treatment of Central Nervous System diseases was founded by Dr. Stieg. The Center’s research program enrolls thousands of patients in clinical trials for novel treatments ranging from degenerative lumbar disc and cognitive impairment to Parkinson’s, Brain Tumors and Epilepsy utilizing the latest therapies in precision medicine. In 2014, he launched the first neuromedical-staffed Concussion Center in New York.
Dr. Stieg also serves as a sideline consultant for the National Football League and a consulting neurosurgeon to the New York Giants, as well as an advisor to the Department of Defense on traumatic brain injury in the military.
BTF Chairman Michael Schreiber
Michael Schreiber became determined to help brain tumor patients and their families after living through his own father’s battle with a brain tumor. He has been actively involved in all aspects of BTF since its inception in 1998.
An influential business and community leader, Michael is President of Royal Farms, a privately owned real estate management firm. Under his leadership BTF has created and implemented many innovative programs including the unprecedented Road to Early Detection initiative, and most recently, the national expansion of that campaign, Sponsor-A-City.
Founding President Patrick J. Kelly, M.D., F.A.C.S.
Dr. Patrick J. Kelly is the retired Joseph Ransohoff Professor of Neurosurgery at NYU School of Medicine. Dr. Kelly is an internationally recognized authority on brain tumor surgery, and a pioneer in stereotactic neurosurgery and computer application in neurosurgery.
Over his long career he has operated on more than 7,500 brain tumors and has seen firsthand the devastation these malignancies – almost always caught too late for effective treatment – can inflict on patients and loved ones. Dr. Kelly is a recipient of the Karolinska Institute’s prestigious Olivecrona Prize, the World Federation of Neurological Societies’ Scoville Achievement Award and the Irish Sir Peter Freyer Medal. Dr. Kelly is past President of the American Society of Stereotactic and Functional Neurosurgery, was Vice President of the World Society of Stereotactic Functional Neurosurgery and a Member of the Medical Advisory Council of the Association for Brain Tumor Research. He has authored more than 230 scientific and clinical papers and book chapters and served on the editorial boards of Neurosurgery, Surgical Neurology, Journal of Stereotactic and Functional Neurosurgery and Neurological Research.
In 1998 Dr. Kelly helped give a focus and voice to the fight against brain cancer by forming the nonprofit Brain Tumor Foundation. He was also the visionary behind the Road to Early Detection campaign, through which BTF has worked to educate medical professionals and the public about the need for the early detection of brain tumors.
Michael Schulder, M.D., President
Michael Schreiber, BTF Chairman
Patrick J. Kelly, M.D., F.A.C.S., Founding President
Philip E. Stieg Ph.D, M.D., President Emeritus
Mary Jo Brown
Thomas A. Donovan
John Golfinos, M.D.
Ted Schwartz, MD
Mark M. Souweidane, MD
Armando Basso, M.D., Ph.D., F.A.C.S.
University of Buenos AiresProfessor and Chairman, Department of Neurosurgery
Mitchel S. Berger, M.D., F.A.C.S. , F.A.A.N.S.
UCSF Department of NeurosurgeryProfessor and Chairman, Department of Neurological Surgery
Berthold and Belle N. Guggenhime Endowed Chair
Director Brain Tumor Surgery Program
Director Neurosurgical Research Centers, Brain Tumor Research Center
Giovanni Broggi, M.D.
Istituto O.Galeazzi, Milan, ItalyDepartment of Neurosurgery, Istituto Neurologico Carlo Besta of Milano, Milan and
Department of Neurosurgery
Jeffrey N. Bruce, M.D., F.A.C.S.
Columbia University Medical CenterEdgar M. Housepian Professor of Neurological Surgery
Vice Chairman of Academic Affairs
Director, Bartoli Brain Tumor Research Laboratory
Co-Director, Brain Tumor Center
Peter Burger, M.D.
Johns Hopkins Medical CenterProfessor of Pathology, Neurosurgery and Oncology
Director of Surgical Neuropathology
J.P. Chodkiewicz, M.D.
Sainte Anne Hospital, Paris, FranceProfessor
Catherine Daumas-Duport, M.D.
Sainte Anne Hospital, Paris, FranceNeuroscience Oncology and Pathology
Bernadine Donahue, M.D.
Maimonides Medical CenterVice Chair & Clinical Director, Radiation Oncology
Mark R. Gillbert, M.D.
NIH National Cancer InstituteChief, Neuro-Oncology Branch
John G. Golfinos, M.D., A.B.
NYU Langone Medical CenterChairman, Department of Neurosurgery
Tessa Hedley-Whyte, M.D.
Massachusetts General HospitalPathologist
Frederick F. Lang, Jr., M.D., F.A.C.S., F.A.A.N.S.
University of Texas, MD Anderson Cancer CenterProfessor (tenure)
Department of Neurosurgery, Division of Surgery
Edward Laws, M.D.
Brigham and Women’s HospitalDirector, Pituitary and Neuroendocrine Center
Jay Loeffler, M.D.
Massachusetts General HospitalChief, Radiation Oncology
Robert L. Martuza, M.D., F.A.C.S.
Massachusetts General HospitalWilliam and Elizabeth Sweet Professor of Neuroscience
Department of Surgery (Neurosurgery)
Harvard Medical School
Chief Neurosurgical Service
Attending Neurosurgeon, Massachusetts General Hospital
Douglas C. Miller, M.D.
University of Missouri School of MedicineClinical Professor of Pathology and Anatomical Sciences
Alfred Neugut, M.D.
Columbia University Mailman School of Public HealthMyron M. Studner Professor of Cancer Research (In Medicine)
at Columbia University Medical Center
Christoph Ostertag, M.D.
Albert-Ludwigs-University Freiburg, GermanyProfessor of Neurosurgery
Dept. of Stereotactic and Functional Neurosurgery
Susan C. Pannullo, M.D.
Weill Cornell Medical Center/Brain and Spine CenterDirector of Neuro-oncology and Director of Neurosurgical Radiosurgery
Jon Robertson, M.D.
University of Tennessee Health Science CenterChairmanship Emeritus, Department of Neurosurgery
Jane Roskams, M.D.
Allen Institute for Brain ScienceExecutive Director
Professor, Departments of Psychiatry and Zoology
Gail L. Rosseau, M.D.
NorthShore Medical GroupDirector, Skull Base Surgery
Theodore H. Schwartz, M.D.
Weill Cornell Brain and Spine CenterProfessor of Neurosurgery, Neurology, and Otolaryngology
Director, Center for Epilepsy and Pituitary Surgery
Co-Director, Surgical Neuro-oncology
David Thomas, M.D.
Riddle Memorial Hospital, Center for Neuroscience, PACampus Chief of Medicine
Chief of Neurology and
Founder/President of The Center for Neuroscience